TANDEM DIABETES CARE INC (TNDM) Stock Overview
USA - NASDAQ:TNDM - US8753722037 - Common Stock
TNDM Key Statistics, Chart & Performance
The current stock price of TNDM is 14.59 USD. In the past month the price increased by 22.08%. In the past year, price decreased by -52.52%.
TNDM Latest News, Press Relases and Analysis
TNDM Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 24.98 | 216.98B | ||
| ISRG | INTUITIVE SURGICAL INC | 61.56 | 190.00B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.09 | 149.02B | ||
| SYK | STRYKER CORP | 28.71 | 141.06B | ||
| MDT | MEDTRONIC PLC | 16.45 | 116.69B | ||
| BDX | BECTON DICKINSON AND CO | 12.57 | 51.42B | ||
| IDXX | IDEXX LABORATORIES INC | 52.33 | 50.28B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.48 | 49.01B | ||
| RMD | RESMED INC | 26.41 | 36.81B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 16.34 | 34.24B | ||
| DXCM | DEXCOM INC | 40.12 | 26.75B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 16.23 | 26.26B |
Related stock screener links
About TNDM
Company Profile
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. The company is headquartered in San Diego, California and currently employs 2,650 full-time employees. The company went IPO on 2013-11-13. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.
Company Info
TANDEM DIABETES CARE INC
12400 High Bluff Drive
San Diego CALIFORNIA 92121 US
CEO: John F. Sheridan
Employees: 2650
Phone: 18583666900
TANDEM DIABETES CARE INC / TNDM FAQ
What does TANDEM DIABETES CARE INC do?
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. The company is headquartered in San Diego, California and currently employs 2,650 full-time employees. The company went IPO on 2013-11-13. Its pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Its t:slim X2 and Tandem Mobi pumps can be used with a variety of infusion sets to offer patients choice in how and where their pump is worn. In addition, they are software updatable from a personal computer and compatible with its Web-based data management application. Both pumps feature its Control-IQ advanced hybrid closed loop technology, with an automated insulin delivery (AID) feature designed to help increase a user's time in the targeted glycemic range. There are two primary therapies used by people with insulin-dependent diabetes, Multiple Daily Injection (MDI) and insulin pumps. As part of its AID systems, it offers pump integration with multiple CGM sensors.
What is the current price of TNDM stock?
The current stock price of TNDM is 14.59 USD. The price decreased by -3.7% in the last trading session.
What is the dividend status of TANDEM DIABETES CARE INC?
TNDM does not pay a dividend.
What is the ChartMill technical and fundamental rating of TNDM stock?
TNDM has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the GICS sector and industry of TNDM stock?
TANDEM DIABETES CARE INC (TNDM) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
When does TANDEM DIABETES CARE INC (TNDM) report earnings?
TANDEM DIABETES CARE INC (TNDM) will report earnings on 2025-11-06, after the market close.
Can you provide the ownership details for TNDM stock?
You can find the ownership structure of TANDEM DIABETES CARE INC (TNDM) on the Ownership tab.
TNDM Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to TNDM. When comparing the yearly performance of all stocks, TNDM is a bad performer in the overall market: 91.79% of all stocks are doing better.
TNDM Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to TNDM. TNDM may be in some trouble as it scores bad on both profitability and health.
TNDM Financial Highlights
Over the last trailing twelve months TNDM reported a non-GAAP Earnings per Share(EPS) of -1.48. The EPS increased by 15.68% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -23.46% | ||
| ROE | -154.15% | ||
| Debt/Equity | 2.32 |
TNDM Forecast & Estimates
29 analysts have analysed TNDM and the average price target is 21.71 USD. This implies a price increase of 48.81% is expected in the next year compared to the current price of 14.59.
For the next year, analysts expect an EPS growth of -45.82% and a revenue growth 9.78% for TNDM